As of November 2024 Taysha Gene Therapies has a market cap of A$0.46 Billion. This makes Taysha Gene Therapies the world's 7375th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 10th, 2024 the market cap of Taysha Gene Therapies was reported to be: